Sport Resolutions opens applications for its 2027–2030 Panel
Sport Resolutions is pleased to announce that applications are now open for its 2027–2030 Panel, with applications welcomed from suitably qualified professionals from around the world
Tue, September 23, 2025
Following a World Anti-Doping Agency (WADA) Executive Committee meeting on 11 September 2025, the agency has issued a revised Technical Document for Dried Blood Spots for Doping Control, a new Technical Document for the detection of an athlete’s illegal use of another person’s red blood cells, and a new Technical Letter concerning the analysis and reporting of clomifene, a substance which significantly increases testosterone levels. The documents and letter will come into effect from 1 January 2026.
Regarding the first Technical Document, Dried Blood Spots (DBS) for Doping Control, major modifications have been made, such as:
Regarding the second Technical Document - Detection of Homologous Blood Transfusion (HBT) by Flow Cytometry, this refers to the detection of an athlete’s illegal use of another person’s red blood cells. This Technical Document clarifies the requirements for HBT test method validation and accreditation. It also sets out the pre-analytical (sample preparation and storage) and analytical procedure requirements, and the criteria for interpretation and reporting of results. It also states that a second opinion is mandatory.
The Technical Letter is titled: Clomifene - Instructions on the Analysis and Reporting of Clomifene Findings in Urine Samples. Clomifene is included in WADA’s Anti-Estrogenic Substances. Anti-oestrogen supplements can be abused in sport to optimise testosterone levels and increase muscle bulk. However, the substance may also be used as a fertility enhancer in hens to increase egg production. Therefore, the presence of the substance in athletes’ urine samples may be the result of food contamination from poultry meat and eggs.
Therefore, the Technical Letter covers the analysis and reporting of clomifene findings. It also sets out a minimum reporting level which is the lowest concentration of a substance that a laboratory can accurately quantify and report for a given sample using a specific analytical method. This is for the clomifene parent compound only, meaning the initial drug molecule administered before undergoing changes like metabolism or conversion into metabolites.
WADA’s official statement can be found here.
Sport Resolutions is pleased to announce that applications are now open for its 2027–2030 Panel, with applications welcomed from suitably qualified professionals from around the world
A decision in the case of the International Tennis Integrity Agency against Ms Jessica Eudovic has been issued by the Independent Tribunal
A peer-reviewed study by the International Testing Agency has confirmed that short-distance drone transport can preserve the integrity of anti-doping samples while significantly reducing transport times compared with road transport